Arterial pH Selectively Predicts Intensive Care Unit Transfer From the Emergency Department in Obese Patients With Acute Dyspnea

Respiratory Failure Clinical Trial

Official title:

Arterial pH Selectively Predicts ICU Transfer in Obese Patients With Acute Dyspnea Presenting to the Emergency Department: a Prospective Comparative Cohort Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03239730
• Other study ID #: pH acute dyspnea
• Status: Completed
• Phase: N/A
• First received: August 1, 2017
• Last updated: August 3, 2017
• Start date: May 23, 2013
• Est. completion date: May 30, 2014

Study information

• Verified date: August 2017
• Source: Association pour la Formation du Personnel à la Medecine d'Urgence
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the prognostic value of arterial blood gas analysis in a cohort of Emergency Department patients presenting with shortness of breath of any cause, comparing obese and non-obese patients.

Description:

Factors associated with admission to intensive care unit (ICU) or ED mortality before transfer to the ICU are analyzed in obese (BMI ≥ 30kg.m-2) and non-obese patients subgroups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 400
• Est. completion date: May 30, 2014
• Est. primary completion date: May 30, 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients who presented with acute dyspnea in the ED

• patients who had an ABG analysis as part of the ED standard management

Exclusion Criteria:

• Patients with treatment limitation decisions made by the medical teams against ICU admission, including severe cognitive impairment or palliative care ,

• Patients with immediate transfer to ICU due to shock and hemodynamic instability at ED admission

Related Conditions & MeSH terms

• Dyspnea
• Emergencies
• Respiratory Failure
• Respiratory Insufficiency

Locations

Country	Name	City	State
France	Montpellier University hospital	Montpellier

Sponsors (2)

Lead Sponsor	Collaborator
Association pour la Formation du Personnel à la Medecine d'Urgence	University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Composite of admission to the ICU or in ED mortality before ICU admission	Admission to the ICU following ED management will be at the discretion of the attending ICU physician, and in agreement with current guidelines for ICU admission, according to standard management	up to 1 day (direct admission to ICU from ED)